DOCSLIB.ORG

Prohibition of 328 Fixed Dose Combination by the Central

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Prohibition of 328 Fixed Dose Combination by the Central LIST OF FDC'S BANNED WITH EFFECT FROM 12-09-2018 AS PER NOTIFICATIONS CIPMMA SL.NO FIXED DOSE COMBINATION NOTIFICATION NO 1 Aceclofenac (SR) + Paracetamol 750 2 Aceclofenac + Paracetamol + Famotidine 744 3 Aceclofenac + Paracetamol + Rabeprazole 705 4 Aceclofenac + Zinc Carnosine 745 5 Acetaminophen + Guaifenesin + Dextromethorphan + Chlorpheniramine 945 6 Acetaminophen + Loratadine + Ambroxol + Phenylephrine 906 7 Acriflavine + Thymol + Cetrimide 1014 8 Acrivastine + Paracetamol + Caffeine + Phenylephrine 915 9 Albuterol + Bromhexine + Theophylline 1033 10 Albuterol + Etofylline + Bromhexine + Menthol 1032 11 Alginic Acid + Sodium Bicarbonate + Dried Aluminium Hydroxide + Magnesium Hydroxide 842 12 Allantoin + Dimethieone + Urea + Propylene + Glycerin + Liquid Paraffin 1013 13 Ambroxol + Levocetirizine + Phenylephrine + Guaiphenesin + Menthol 956 14 Ambroxol + Guaifenesin + Phenylephrine + Chlorpheniramine 927 15 Ambroxol + Salbutamol + Choline Theophyllinate + Menthol 987 16 Ambroxol + Salbutamol + Theophylline 942 17 Ambroxol + Terbutaline + Dextromethorphan 895 18 Ambroxol+ Guaiphenesin + Ammonium Chloride + Phenylephrine + Chlorpheniramine Maleate + Menthol 872 19 Ammonium Chloride + Dextromethorphan + Cetirizine + Menthol 964 20 Ammonium Chloride + Sodium Citrate + Chlorpheniramine Maleate + Menthol 740 21 Ammonium Citrate + Vitamin B 12 + Folic Acid + Zinc Sulphate 1042 22 Amoxicillin + Cefixime + Potassium Clavulanic Acid 757 23 Amoxicillin + Dicloxacillin 753 24 Amoxicillin 250 mg + Potassium Clavulanate Diluted 62.5 754 25 Amoxycillin + Dicloxacillin + Serratiopeptidase 771 26 Amoxycillin + Tinidazole 764 27 Ascorbic Acid + Manadione Sodium Bisulphate + Rutin + Dibasic Calcium Phosphate + Adrenochrome mono Se 1046 28 Atorvastatin + Vitamin D3 + Folic Acid + Vitamin B12 + Pyridoxine 784 29 Azithromycin + Acebrophylline 865 30 Azithromycin + Ambroxol 781 31 Azithromycin + Cefixime 752 32 Azithromycin + Cefpodoxime 772 33 Azithromycin + Levofloxacin 755 34 Azithromycin + Ofloxacin 763 35 Becloemthasone + Clotrimazole + Chloramphenicol + Gentamycin + Lignocaine Ear drops 831 36 Beclomethasone + Clotimazole + Neomycin + lodochlorohydroxyquinone 1007 37 Beclomethasone + Clotrimazole + Gentamicin + lodochlorhydroxyquinoline 1040 38 Beclomethasone Diproprionate + Neomycin + Tolnaftate + lodochlorhydroxyquinoline + Chlorocresol 1020 39 Benfotiamine + Metformin 1044 40 Benzoxonium Chloride + Lidocaine 735 41 Betahistine + Ginkgo Biloba Extract + Vinpocetine + Piracetam 791 42 Betamethasone + Fusidic Acid + Gentamycin + Tolnaftate + lodochlorhydroxyquinoline (ICHQ) 1002 43 Betamethasone + Gentamicin + Tolnaftate + lodochlorhydroxyquinoline 1011 44 Betamethasone + Gentamycin + Zinc Sulphate + Clotrimoazole + Chlorocresol 1021 45 Betamethasone + Neomycin + Tolnaftate + lodochlorohydroxyquinoline + Cholorocresol 1015 46 Borax + Boric Acid + Naphazoline + Menthol + Camphor + Methyl Hydroxy Benzoate 1022 47 Bromhenxine + Phenylephrine + Chlorpheniramine + Paracetamol 1039 48 Bromhexine + Cetrizine + Phenylephrine IP+Guaifenesin + Menthol 990 49 Bromhexine + Dextromethorphan 1023 50 Bromhexine + Dextromethorphan + Phenylephrine + Menthol 883 51 Bromhexine + Phenylephrine + Chlorepheniramine Maleate 861 52 Caffeine + Paracetamol + Chlorpheniramine 963 53 Caffeine + Paracetamol + Phenylephrine + Cetirizine 954 54 Calcium Gluconate + Chlorpheniramine + Vitamin C 998 55 Calcium Gluconate + Levocetirizine 994 56 Cefixime + Levofloxacin 766 57 Cefixime + Linezolid 756 58 Cefpodoxime Proxetil + Levofloxacin 759 59 Cefuroxime + Linezolid 774 60 Cephalexin + Neomycin + Prednisolone 780 61 Certirizine + Phenylephrine + Paracetamol + Caffeine + Nimesulide 985 62 Cetirizine + Acetaminophen + Dextromethorphan + Phenyephrine + Zinc Gluconate 907 63 Cetirizine + Ambroxol + Guaiphenesin + Ammonium Chloride + Phenylephrine + Menthol 876 64 Cetirizine + Dextromethorphan + Ambroxol 925 65 Cetirizine + Dextromethorphan + Bromhexine + Guaifenesin 937 66 Cetirizine + Dextromethorphan + Phenylephrine + Tulsi 946 67 Cetirizine + Dextromethorphan + Phenylephrine + Zinc Gluconate + Paracetamol + Menthol 887 68 Cetirizine + Dextromethorphan + Zinc Gluconate + Menthol 910 69 Cetirizine + Diethyl Carbamazine 792 70 Cetirizine + Phenylephrine + Dextromethorphan + Menthol 903 71 Cetirizine + Phenylephrine + Paracetamol + Ambroxol + Caffeine 947 72 Cetirizine + Phenylephrine + Paracetamol + Zinc Gluconate 871 73 Cetririzine + Nimesulide + Phenylephrine 943 74 Chlopheniramine Maleate + Dextromethorphan + Guaiphensin + Phenylephrine 962 75 Chloramphenicol + Beclomethasone + Clomitrimazole + Lignocaine 825 76 Chloramphennicol + Lignocaine + Betamethasone + Clotrimazole + Ofloxacin + Antipyrine 827 77 Chlorphaniramine + Ammonium Chloride + Sodium Chloride 933 78 Chlorpheniramine + Ammonium Chloride + Chloroform + Menthol 981 79 Chlorpheniramine + Ammonium Chloride + Noscapine + Sodium Citrate 936 80 Chlorpheniramine + Codeine + Sodium Citrate + Menthol Syrup 881 81 Chlorpheniramine + Dextromethorphan + Phenylephrine + Paracetamol 890 82 Chlorpheniramine + Paracetamol + Pseudoephedrine + Caffeine 999 83 Chlorpheniramine + Phenylephrine + Caffeine 877 84 Chlorpheniramine + Phenylephrine + Dextromethophan + Menthol 894 85 Chlorpheniramine + Phenylephrine + Paracetamol + Zink Gluconate 944 86 Chlorpheniramine + Terpin + Antimony Potassium Tartrate + Ammonium Chloride + Sodium Citrate + Menthol 966 87 Chlorpheniramine + Vasaka + Tolubalsm + Ammonium Chloride + Sodium Citrate + Menthol 989 88 Chlorpheniramine + Vitamin C 997 89 Chlorpheniramine Maleate + Ammonium Chloride + Sodium Citrate 870 90 Chlorpheniramine+Ammonium Chloride + Menthol 970 91 Chlorpromazine + Trihexyphenidyl 800 92 Chromium Polynicotinate + Metformin 819 93 Cilnidipine + Metoprolol Succinate + Metoprolol Tartrate 782 94 Ciprofloxacin + Fluocinolone + Clotrimazole + Neomycin + Chlorocresol 1009 95 Ciprofloxacin + Fluticasone + Clotrimazole + Neomycin 778 96 Ciprofloxacin + Phenazopyridine 770 97 Clidinium + Paracetamol + Dicyclomine + Activated Dimethicone 843 98 Clindamycin + Clotrimazole + Lactic Acid Bacillus 854 99 Clindamycin + Telmisartan 786 100 Clobetasol + Gentamicin + Tolnaftate + lodochlorhydroxyquinone + Ketoconazole 1012 101 Clobetasol + Neomycin + Miconazole + Clotrimazole 1016 102 Clobetasol + Neomycin + Miconazole + Zinc Sulphate 1019 103 Clobetasol + Ofloxacin + Ketoconazol + Zinc Sulphate 1010 104 Clobetasol + Ofloxacin + Miconazole + Zinc Sulphate 1003 105 Clobetasol Propionate + Ofloxacin + Ornidazole + Terbinafine 1018 106 Clobetasole + Gentamicin + Miconazole + Zinc Sulphate 1004 107 Clomifene Citrate + Ubidecarenone + Zinc + Folic Acid + Methylcobalamin + Pyridoxine + Lycopene + Selenium + Levocarnitine Tartrate + L-Arginine 856 108 Clotrimazole + Beclomethasone + Lignocaine + Ofloxacin + Acetic Aicd + Sodium Methyl Paraben + Propyl Paraben 1048 109 Clotrimazole + Beclomethasone + Ofloxacin + Lignocaine 830 110 Clotrimazole + Ofloxaxin + Lignocaine + Glycerine and Propylene Glycol 826 111 Codeine + Chlorpheniramine + Alcohol Syrup 920 112 Codeine + Levocetirizine + Menthol 901 113 Combikit of 3 tablets of Serratiopeptidase (enteric coated 20000 units) + Diclofenac Potassium & 2 tablets of D 742 114 Combikit of Azithromycin, Secnidazole and Fluconazole 760 115 Combikit of Fluconazole Tablet, Azithromycin Tablet and Ornidazole Tablets 769 116 Cyproheptadine + Thiamine 835 117 Dextrometharphan + Chlopheniramine + Ammonium Chloride+ Menthol 958 118 Dextrometharphan + Chlopheniramine + Ammonium + Sodium Citrate + Menthol 1026 119 Dextrometharphan + Phenylephrine + Guaiphenesin 955 120 Dextromethophan + Chlopheniramine + Bromhexine 1024 121 Dextromethorphan + Ambroxol + Ammonium Chloride + Chlorpheniramine + Menthol 991 122 Dextromethorphan + Ambroxol + Guaifenesin + Phenylephrine + Chlorpheniramine 902 123 Dextromethorphan + Bromhexine + Guaiphenesin 862 124 Dextromethorphan + Bromhexine + Guaiphenesin + Menthol 914 125 Dextromethorphan + Cetirizine 917 126 Dextromethorphan + Cetirizine + Guaifenesin + Ammonium Chloride 986 127 Dextromethorphan + Chlorpheniramine + Chlorpheniramine Maleate 875 128 Dextromethorphan + Chlorpheniramine + Guaiphenesin 896 129 Dextromethorphan + Levocetirizine + Phenylephrine + Zinc 859 130 Dextromethorphan + Paracetamol + Cetirizine + Phenylephrine 965 131 Dextromethorphan + Phenylephrine + Ammonium Chloride + Menthol 913 132 Dextromethorphan + Phenylephrine + Bromhexine + Guaifenesin + Chlorpheniramine 974 133 Dextromethorphan + Phenylephrine + Cetirizine + Paracetamol + Caffeine 929 134 Dextromethorphan + Phenylephrine + Cetirizine + Zinc + Menthol 992 135 Dextromethorphan + Phenylephrine + Guaifenesin + Certirizine + Acetaminophen 979 136 Dextromethorphan + Phenylephrine + Guaifenesin + Triprolidine 921 137 Dextromethorphan + Phenylephrine + Tripolidine + Menthol 972 138 Dextromethorphan + Phenylephrine + Zinc Gluconate + Menthol 880 139 Dextromethorphan + Tripolidine + Phenylephirine 898 140 Dextromethorphan + Triprolidine + Phenylephrine 878 141 Dextromethorphen + Bromhexine + Chlorpheniramine Maleate + Guaiphenesin 873 142 Dextromethorphen + Promethazine 891 143 Diclofenac + paracetamol + chlorpheniramine maleate + mgnesium Trisillicate 725 144 Diclofenac + Paracetamol + Chlorzoxazone + Famotidine 715 145 Diclofenac + paracetamol + magnesium Trisilicate 738 146 Diclofenac + Paracetamol injection 751 147 Diclofenac + Tramadol + Chlorzoxazone 710 148 Diclofenac + Tramadol + Paracetamol 714 149 Diclofenac + Zinc Carnosine 724 150 Dicyclomine + Paracetamol
Load more

Recommended publications
  • Effect of Theophylline and Enprofylline on Bronchial Hyperresponsiveness
    Thorax: first published as 10.1136/thx.44.12.1022 on 1 December 1989. Downloaded from Thorax 1989;44:1022-1026 Effect of theophylline and enprofylline on bronchial hyperresponsiveness G H KOETER, J KRAAN, M BOORSMA, J H G JONKMAN, TH W VAN DER MARK From the Department ofPulmonology and Lung Function, University Hospital, Groningen; Pharma Bio Research, Assen; and Astra Pharmaceutica, Rijswijk, The Netherlands ABSTRACT The effect of increasing intravenous doses of theophylline and enprofylline, a new xanthine derivative, on bronchial responsiveness to methacholine was studied in eight asthmatic patients. Methacholine provocations were carried out on three days before and after increasing doses of theophylline, enprofylline, and placebo, a double blind study design being used. Methacholine responsiveness was determined as the provocative concentration of methacholine causing a fall of 20% in FEV, (PC20). The patients were characterised pharmacokinetically before the main study to provide an individual dosage scheme for each patient that would provide rapid steady state plasma concentration plateaus of 5, 10, and 15 mg/l for theophylline and 1 25, 2 5, and 3-75 mg/l for enprofylline. Dose increments in the main study were given at 90 minute intervals. FEV, showed a small progressive decrease after placebo; it remained high in relation to placebo after both drugs and this effect was dose related. Methacholine PC20 values decreased after placebo; mean values were (maximum difference 2-0 and 1 7 higher after theophylline and enprofylline than after placebo copyright. doubling doses of methacholine); the effect of both drugs was dose related. Thus enprofylline and theophylline when given intravenously cause a small dose related increase in FEV1 and methacholine PC20 when compared with placebo.
    [Show full text]
  • Memory Enhancers for Alzheimer's Dementia
    pharmaceuticals Review Memory Enhancers for Alzheimer’s Dementia: Focus on cGMP Ernesto Fedele 1,2,* and Roberta Ricciarelli 2,3,* 1 Department of Pharmacy, Section of Pharmacology and Toxicology, University of Genoa, 16148 Genova, Italy 2 IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy 3 Department of Experimental Medicine, Section of General Pathology, University of Genoa, 16132 Genova, Italy * Correspondence: [email protected] (E.F.); [email protected] (R.R.) Abstract: Cyclic guanosine-30,50-monophosphate, better known as cyclic-GMP or cGMP, is a classical second messenger involved in a variety of intracellular pathways ultimately controlling different physiological functions. The family of guanylyl cyclases that includes soluble and particulate en- zymes, each of which comprises several isoforms with different mechanisms of activation, synthesizes cGMP. cGMP signaling is mainly executed by the activation of protein kinase G and cyclic nucleotide gated channels, whereas it is terminated by its hydrolysis to GMP operated by both specific and dual-substrate phosphodiesterases. In the central nervous system, cGMP has attracted the attention of neuroscientists especially for its key role in the synaptic plasticity phenomenon of long-term potentiation that is instrumental to memory formation and consolidation, thus setting off a “gold rush” for new drugs that could be effective for the treatment of cognitive deficits. In this article, we summarize the state of the art on the neurochemistry of the cGMP system and then review the pre-clinical and clinical evidence on the use of cGMP enhancers in Alzheimer’s disease (AD) therapy. Although preclinical data demonstrates the beneficial effects of cGMP on cognitive deficits in AD animal models, the results of the clinical studies carried out to date are not conclusive.
    [Show full text]
  • Gedeon Richter Annual Report Gedeon Richtergedeon • Annual Report • 2011
    GEDEON RICHTER ANNUAL REPORT GEDEON RICHTERGEDEON • ANNUAL REPORT • 2011 1901 2011 00Borito_annual_report_angol_2012_140_old.indd 1 3/25/12 2:29 PM Delivering quality therapy through generations 2011 01_angol_elso_resz_01_66.indd 1 3/26/12 2:23 PM 2 Contents CONTENTS Richter Group – Fact Sheet . 3 Consolidated Financial Highlights . 5 Chairman’s Statement . 7 Directors’ Report . 9 Information for Shareholders . 9 Shareholders’ Highlights . 9 Market Capitalisation . 9 Annual General Meeting . 10 Investor Relations Activities . 10 Dividend . 11 Information Regarding Richter Shares . 12 Shares in Issue . 12 Treasury Shares . 12 Registered Shareholders . 12 Share Ownership by Company Board Members . 13 Risk Management . 14 Corporate Governance . 16 Company’s Boards . 18 Board of Directors . 18 Executive Board . 21 Supervisory Committee . .22 Managing Director’s Review . 25 Operating Review . 29 Consolidated Turnover . 29 Markets – Pharmaceutical Segment . 31 Hungary . 32 International Sales . 34 European Union . 35 CIS . 37 USA . 38 Rest of the World . 38 Wholesale and Retail Activities . 39 Research and Development . 40 Female Healthcare . 42 Products . 46 Manufacturing and Supply . 50 Corporate Social Responsibility . 51 Environmental Policy . 51 Health and Safety at Work . 52 Work Health and Safety Management System . 52 Practical Implementation . 52 Community Involvement . 53 People . 54 Employees . 54 Recruitment and Individual Development . 55 Developing Leaders . 56 Remuneration and Other Employee Programmes . 56 Financial Review . 59 Key Financial Data . 59 Cost of Sales . 59 Gross Profit . 59 Operating Expenses . 60 Profit from Operations . 61 Net Financial Income . 61 Share of Profit of Associates . 62 Income Tax . 62 Profit for the Year . 62 Profit Attributable to Owners of the Parent . 62 Balance Sheet . 63 Cash Flow .
    [Show full text]
  • Review on Vinpocetine
    Review Article ISSN: 0976-7126 CODEN (USA): IJPLCP Dubey et al., 11(5):6590-6597, 2020 [[ Review on Vinpocetine Anubhav Dubey*, Neeraj Kumar, Ashish Mishra, Yatendra Singh and Mamta Tiwari 1, Department of Pharmacology, Advance Institute of Biotech and Paramedical Sciences Kanpur (U.P.) - India Abstract Article info Vinpocetine is a synthetic ethyl ester of apovincamine. It is extracted from the periwinkle plant. Vincamine is extracted from either Received: 12/03/2020 the seeds of Voacanga-Africana or the leaves. Vinpocetine is an herbal supplement used to treat various neurological disorders such as Revised: 29/04/2020 Alzheimer’s and Parkinson’s disease. Vinpocetine has also anti- inflammatory, analgesics, antioxidant property and treat various thinking Accepted: 26/05/2020 and memory problem. The drug has neuroprotective property thus it is used for memory impairment. Vinpocetine drug dilates blood vessels and © IJPLS promotes cerebral blood flow. Pharmacodynamics, Pharmacokinetic and adverse effects were discussed. www.ijplsjournal.com Keywords: Vincamine, neuroprotective, memory enhancement and cerebral blood flow Voacanga-Africana Introduction Vinpocetine was prepared under the trade name possible mechanism by which cerebral ATP levels cavinton in 1978[1], vinpocetine widely used in seemed to be increased after administration of the Germany, Russia, Japan, Hungar for the treatment compound. [3] of the cerebrovascular related disorder. Modern lifestyle has raised life hope but also Vinpocetine is a semi-synthetic derivative increase chronic harm full disease, therefore, obtained from vincamine alkaloid. Vincamine increasing chronic Pharmaceutical usage, it is also present in the aerial part of the vinca minor and called some time nootropic agent meaning plant belongs to the Apocynaceae family.
    [Show full text]
  • 12.2% 122,000 135M Top 1% 154 4,800
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE We are IntechOpen, provided by IntechOpen the world’s leading publisher of Open Access books Built by scientists, for scientists 4,800 122,000 135M Open access books available International authors and editors Downloads Our authors are among the 154 TOP 1% 12.2% Countries delivered to most cited scientists Contributors from top 500 universities Selection of our books indexed in the Book Citation Index in Web of Science™ Core Collection (BKCI) Interested in publishing with us? Contact [email protected] Numbers displayed above are based on latest data collected. For more information visit www.intechopen.com Chapter A Detail Chemistry of Coffee and Its Analysis Hemraj Sharma Abstract This review article highlights the detailed chemistry of coffee including its components; chemical constituents like carbohydrates, proteins, lipids, and caf- feine; aromatic principles; oil and waxes; and minerals and acids. The high extent of caffeine can be found in the coffee plants; hence, in the second part of the study, various analytical methods are designed for the proper identification, separation, optimization, purification, and determination of caffeine present in coffee, tea, and marketed coffee. These analytical methods are appropriated for the separation and quantification of caffeine. The various analytical methods include spectroscopy methods like UV, IR, and NMR spectroscopy; chromatographic methods like paper, TLC, column, HPLC, and gas chromatography; and hyphenated techniques like LC–MS, GC–MS, and GC–MS/MS. This article compares and contrasts the amount of caffeine by various analytical methods. Keywords: caffeine, spectrophotometer, chromatography, hyphenated techniques, electrochemical methods 1.
    [Show full text]
  • Effect of Practical Timing of Dosage on Theophylline Blood Levels In
    Arch Dis Child: first published as 10.1136/adc.53.2.167 on 1 February 1978. Downloaded from Archives of Disease in Childhood, 1978, 53, 167-182 Short reports Effect of practical timing of dosage Methods on theophylline blood levels in For the period of the study, the children did not asthmatic children treated with receive tea, which contains theophylline. choline theophyllinate GroupA. These childrenwere given choline theophyll- The bronchodilator effect of theophylline has been inate in a dosage of as near as possible 8 mg/kg per known for over 50 years, but although it has been dose qds (mean 7 9 mg/kg, range 7-2-8 7 mg/kg), widely used both intravenously and rectally in the starting with half the dose on the first day to try and treatment ofacute asthma, its use as an oral broncho- minimise nausea. The doses were given at 0800 h, dilator has been limited by inadequate knowledge of 1300 h, 1700 h, and 2100 h, times considered suitable the correct dosage of the oral preparations. The for administration outside hospital. On the third day therapeutic level of theophylline is generally con- ofthe study serum levels were measured 2 hours after sidered to be between 10 and 20 ,ug/ml (Turner- each dose and before the 0800 h dose the following Warwick, 1957; Jenne et al., 1972), although sub- morning. optimal bronchodilation can be achieved with levels of 5 ,ug/ml or less (Maselli et al., 1970; Nicholson and Group B. These children were given cholinetheophyll- Chick, 1973). Serious toxicity with levels of less than inate in a dosage of as near as possible 10 mg/kg per copyright.
    [Show full text]
  • Pharmaceuticals 2010, 3, 725-747; Doi:10.3390/Ph3030725
    Pharmaceuticals 2010, 3, 725-747; doi:10.3390/ph3030725 OPEN ACCESS pharmaceuticals ISSN 1424-8247 www.mdpi.com/journal/pharmaceuticals Review Theophylline Peter J. Barnes National Heart and Lung Institute, Imperial College, London, UK; E-Mail: [email protected]; Tel.: +44-207-351-8174; Fax: +44-207-351-5675. Received: 14 January 2010 / Accepted: 18 March 2010 / Published: 18 March 2010 Abstract: Theophylline (3-methyxanthine) has been used to treat airway diseases for over 70 years. It was originally used as a bronchodilator but the relatively high doses required are associated with frequent side effects, so its use declined as inhaled β2-agonists became more widely used. More recently it has been shown to have anti-inflammatory effects in asthma and COPD at lower concentrations. The molecular mechanism of bronchodilatation is inhibition of phosphodiesterase(PDE)3 and PDE4, but the anti-inflammatory effect may be due to histone deacetylase (HDAC) activation, resulting in switching off of activated inflammatory genes. Through this mechanism theophylline also reverses corticosteroid resistance and this may be of particular value in severe asthma and COPD where HDAC2 activity is markedly reduced. Theophylline is given systemically (orally as slow-release preparations for chronic treatment and intravenously for acute exacerbations of asthma) and blood concentrations are determined mainly by hepatic metabolism, which may be increased or decreased in several diseases and by concomitant drug therapy. Theophylline is now usually used as an add-on therapy in asthma patients not well controlled on inhaled corticosteroids and in COPD patients with severe disease not controlled by bronchodilator therapy.
    [Show full text]
  • Estonian Statistics on Medicines 2016 1/41
    Estonian Statistics on Medicines 2016 ATC code ATC group / Active substance (rout of admin.) Quantity sold Unit DDD Unit DDD/1000/ day A ALIMENTARY TRACT AND METABOLISM 167,8985 A01 STOMATOLOGICAL PREPARATIONS 0,0738 A01A STOMATOLOGICAL PREPARATIONS 0,0738 A01AB Antiinfectives and antiseptics for local oral treatment 0,0738 A01AB09 Miconazole (O) 7088 g 0,2 g 0,0738 A01AB12 Hexetidine (O) 1951200 ml A01AB81 Neomycin+ Benzocaine (dental) 30200 pieces A01AB82 Demeclocycline+ Triamcinolone (dental) 680 g A01AC Corticosteroids for local oral treatment A01AC81 Dexamethasone+ Thymol (dental) 3094 ml A01AD Other agents for local oral treatment A01AD80 Lidocaine+ Cetylpyridinium chloride (gingival) 227150 g A01AD81 Lidocaine+ Cetrimide (O) 30900 g A01AD82 Choline salicylate (O) 864720 pieces A01AD83 Lidocaine+ Chamomille extract (O) 370080 g A01AD90 Lidocaine+ Paraformaldehyde (dental) 405 g A02 DRUGS FOR ACID RELATED DISORDERS 47,1312 A02A ANTACIDS 1,0133 Combinations and complexes of aluminium, calcium and A02AD 1,0133 magnesium compounds A02AD81 Aluminium hydroxide+ Magnesium hydroxide (O) 811120 pieces 10 pieces 0,1689 A02AD81 Aluminium hydroxide+ Magnesium hydroxide (O) 3101974 ml 50 ml 0,1292 A02AD83 Calcium carbonate+ Magnesium carbonate (O) 3434232 pieces 10 pieces 0,7152 DRUGS FOR PEPTIC ULCER AND GASTRO- A02B 46,1179 OESOPHAGEAL REFLUX DISEASE (GORD) A02BA H2-receptor antagonists 2,3855 A02BA02 Ranitidine (O) 340327,5 g 0,3 g 2,3624 A02BA02 Ranitidine (P) 3318,25 g 0,3 g 0,0230 A02BC Proton pump inhibitors 43,7324 A02BC01 Omeprazole
    [Show full text]
  • The Use and Impact of Cognitive Enhancers Among University Students: a Systematic Review
    brain sciences Systematic Review The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review Safia Sharif 1 , Amira Guirguis 1,2,* , Suzanne Fergus 1,* and Fabrizio Schifano 1 1 Psychopharmacology, Substance Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK; [email protected] (S.S.); [email protected] (F.S.) 2 Institute of Life Sciences 2, Swansea University, Swansea SA2 8PP, Wales, UK * Correspondence: [email protected] (A.G.); [email protected] (S.F.) Abstract: Introduction: Cognitive enhancers (CEs), also known as “smart drugs”, “study aids” or “nootropics” are a cause of concern. Recent research studies investigated the use of CEs being taken as study aids by university students. This manuscript provides an overview of popular CEs, focusing on a range of drugs/substances (e.g., prescription CEs including amphetamine salt mixtures, methylphenidate, modafinil and piracetam; and non-prescription CEs including caffeine, cobalamin (vitamin B12), guarana, pyridoxine (vitamin B6) and vinpocetine) that have emerged as being misused. The diverted non-prescription use of these molecules and the related potential for dependence and/or addiction is being reported. It has been demonstrated that healthy students (i.e., those without any diagnosed mental disorders) are increasingly using drugs such as methylphenidate, a mixture of dextroamphetamine/amphetamine, and modafinil, for the purpose of increasing their alertness, concentration or memory. Aim: To investigate the level of knowledge, perception and impact of the use of a range of CEs within Higher Education Institutions.
    [Show full text]
  • Potential Herb–Drug Interactions in the Management of Age-Related Cognitive Dysfunction
    pharmaceutics Review Potential Herb–Drug Interactions in the Management of Age-Related Cognitive Dysfunction Maria D. Auxtero 1, Susana Chalante 1,Mário R. Abade 1 , Rui Jorge 1,2,3 and Ana I. Fernandes 1,* 1 CiiEM, Interdisciplinary Research Centre Egas Moniz, Instituto Universitário Egas Moniz, Quinta da Granja, Monte de Caparica, 2829-511 Caparica, Portugal; [email protected] (M.D.A.); [email protected] (S.C.); [email protected] (M.R.A.); [email protected] (R.J.) 2 Polytechnic Institute of Santarém, School of Agriculture, Quinta do Galinheiro, 2001-904 Santarém, Portugal 3 CIEQV, Life Quality Research Centre, IPSantarém/IPLeiria, Avenida Dr. Mário Soares, 110, 2040-413 Rio Maior, Portugal * Correspondence: [email protected]; Tel.: +35-12-1294-6823 Abstract: Late-life mild cognitive impairment and dementia represent a significant burden on health- care systems and a unique challenge to medicine due to the currently limited treatment options. Plant phytochemicals have been considered in alternative, or complementary, prevention and treat- ment strategies. Herbals are consumed as such, or as food supplements, whose consumption has recently increased. However, these products are not exempt from adverse effects and pharmaco- logical interactions, presenting a special risk in aged, polymedicated individuals. Understanding pharmacokinetic and pharmacodynamic interactions is warranted to avoid undesirable adverse drug reactions, which may result in unwanted side-effects or therapeutic failure. The present study reviews the potential interactions between selected bioactive compounds (170) used by seniors for cognitive enhancement and representative drugs of 10 pharmacotherapeutic classes commonly prescribed to the middle-aged adults, often multimorbid and polymedicated, to anticipate and prevent risks arising from their co-administration.
    [Show full text]
  • Piracetam from Wikipedia, the Free Encyclopedia
    Piracetam From Wikipedia, the free encyclopedia Systematic (IUPAC) name 2-oxo-1-pyrrolidineacetamide Clinical data Breinox, Dinagen, Lucetam, Nootropil, Nootropyl, Trade names Oikamid, and many others AHFS/Drugs.com International Drug Names Pregnancy cat. ? Legal status POM (UK) Routes Oral and parenteral Pharmacokinetic data Bioavailability ~100% Half-life 4 - 5 hr Excretion Urinary Identifiers CAS number 7491-74-9 ATC code N06 BX03 PubChem CID 4843 ChemSpider 4677 UNII ZH516LNZ10 KEGG D01914 ChEMBL CHEMBL36715 Chemical data Formula C6H10N2O2 SMILES eMolecules & PubChem InChI Piracetam (sold under many brand names) is a nootropic drug. Piracetam's chemical name is 2-oxo-1- pyrrolidine acetamide; it shares the same 2-oxo-pyrrolidone base structure with 2-oxo-pyrrolidine carboxylic acid(pyroglutamate). Piracetam is a cyclic derivative of GABA. It is one of the group of racetams. Piracetam is prescribed by doctors for some conditions, mainly myoclonus,[1] but is used off-label for a much wider range of applications. Popular trade names for Piracetam in Europe are "Nootropil" and "Lucetam", among many others. In South America, it is made by Laboratorios Farma S.A. and sold under the brand name of Breinox in Venezuela and Ecuador. Contents • 1 Effects • 2 Mechanisms of action • 3 History • 4 Approval and usage • 4.1 Aging • 4.2 Alcoholism • 4.3 Alzheimer's and senile dementia • 4.4 Clotting, coagulation, vasospastic disorders • 4.5 Depression and anxiety • 4.6 Stroke, ischemia and symptoms • 4.7 Dyspraxia and dysgraphia • 4.8 Schizophrenia • 4.9 Preventive for breath-holding spells • 4.10 Closed craniocerebral trauma • 5 Dosage • 6 Side effects • 7 Availability • 8 Notes • 9 See also • 10 References • 11 External links Effects There is very little data on piracetam's effect on healthy people, with most studies focusing on people with seizures, dementia, concussions, or other neurological problems.
    [Show full text]
  • PDE4 and PDE5 Regulate Cyclic Nucleotide Contents and Relaxing Effects on Carbachol-Induced Contraction in the Bovine Abomasum
    Advance Publication The Journal of Veterinary Medical Science Accepted Date: 16 Sep 2014 J-STAGE Advance Published Date: 15 Oct 2014 FULL PAPER Pharmacology PDE4 and PDE5 regulate Cyclic Nucleotide Contents and Relaxing Effects on Carbachol-induced Contraction in the Bovine Abomasum Takeharu KANEDA1)*, Yuuki KIDO1), 2), Tsuyoshi TAJIMA1), Norimoto URAKAWA1) and Kazumasa SHIMIZU1) 1)Laboratory of Veterinary Pharmacology, School of Veterinary Medicine, and 2)School of Veterinary Nursing and Technology, Nippon Veterinary and Life Science University, 7-1 Kyonan-cho 1-chome, Musashino, Tokyo 180-8602, Japan *Correspondence to: Takeharu KANEDA, Laboratory of Veterinary Pharmacology, School of Veterinary Medicine, Nippon Veterinary and Life Science University, 7-1 Kyonan-cho 1-chome, Musashino, Tokyo 180-8602, Japan Tel. +81-422-31-4457 Fax +81-422-31-4457 E-mail [email protected] Running head: PDE4 and PDE5 in the Bovine Abomasum ABSTRACT. The effects of various selective phosphodiesterase（PDE）inhibitors on carbachol (CCh)-induced contraction in the bovine abomasum were investigated. Various selective PDE inhibitors, vinpocetine (type 1), erythro-9-(2- hydroxy-3-nonyl)adenine (EHNA, type 2), milrinone (type 3), Ro20-1724 (type 4), vardenafil (type 5), BRL-50481 (type 7) and BAY73-6691 (type 9), inhibited CCh-induced contractions in a concentration-dependent manner. Among the PDE inhibitors, Ro20-1724 and vardenafil induced more relaxation than the other inhibitors based on the data for the IC50 or maximum relaxation. In smooth muscle of the bovine abomasum, we showed the expression of PDE4B, 4C, 4D and 5 by RT-PCR analysis. In the presence of CCh, Ro20-1724 increased the cAMP content, but not the cGMP content.
    [Show full text]